Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart Study

被引:64
作者
Brilakis, Emmanouil S. [1 ,2 ]
Khera, Amit [2 ]
McGuire, Darren K. [2 ]
See, Raphael [2 ]
Banerjee, Subhash [1 ,2 ]
Murphy, Sabina A. [3 ]
de Lemos, James A. [2 ]
机构
[1] Dallas VA Med Ctr 111A, Dallas, TX 75216 USA
[2] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
lipoprotein-associated phospholipase A2; race; sex factors;
D O I
10.1016/j.atherosclerosis.2007.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Most lipoprotein-associated phospholipase A2 (Lp-PLA2) studies included mainly white men. We sought to determine whether Lp-PLA2 levels differ according to race and sex. Methods: Lp-PLA2 mass and activity were measured in 3332 subjects age 30-65 participating in the Dallas Heart Study, a multiethnic, population-based, probability sample. Lp-PLA2 levels were compared between different race and sex groups. Results: Mean age was 45 +/- 9 years and 44% were men; 30% were white, 17% hispanic, and 53% black. Mean Lp-PLA2 activity and mass were 146 +/- 140 nmol/min/mL and 191 +/- 60 ng/mL, respectively. Lp-PLA2 activity was lower in women compared with men (134 +/- 35 vs. 161 +/- 40, p = 0.001) and was lowest in black (136 +/- 38), intermediate in hispanic (151 +/- 36), and highest in white subjects (161 +/- 39) (trend p = 0.0001). In multivariable linear regression models, after adjusting for age, body mass index (BMI), smoking, total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides and high sensitivity C-reactive protein (hsCRP), Lp-PLA2 activity was 19 nmol/min/mL higher in men vs. women (p < 0.001); compared with black subjects, adjusted Lp-PLA2 activity was 11 and 20 nmol/min/mL higher in white and hispanic subjects, respectively (both p < 0.001). Similar race and sex differences were observed for Lp-PLA2 mass. Conclusion: Race and sex independently influence Lp-PLA2 activity and mass. Thresholds to define Lp-PLA2 elevation may need to be sex and race specific. Published by Elsevier Ireland Ltd.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 30 条
[1]   Relation of coronary atherosclerosis determined by election beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study) [J].
Abdullah, SM ;
Khera, A ;
Das, SR ;
Stanek, HG ;
Canham, RM ;
Chung, AK ;
Morrow, DA ;
Drazner, MH ;
McGuire, DK ;
de Lemos, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (09) :1284-1289
[2]   Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe [J].
Abuzeid, AM ;
Hawe, E ;
Humphries, SE ;
Talmud, PJ .
ATHEROSCLEROSIS, 2003, 168 (02) :283-288
[3]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, P ;
Folsom, AR ;
Chambless, LE ;
Myerson, M ;
Wu, KK ;
Sharrett, AR ;
Boerwinkle, E .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2479-2484
[4]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[5]   A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women [J].
Blake, GJ ;
Dada, N ;
Fox, JC ;
Manson, JE ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) :1302-1306
[6]  
Brilakis E, 2003, CIRCULATION, V107, pE153
[7]   Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up [J].
Brilakis, ES ;
McConnell, JP ;
Lennon, RJ ;
Elesber, AA ;
Meyer, JG ;
Berger, PB .
EUROPEAN HEART JOURNAL, 2005, 26 (02) :137-144
[8]   Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis -: Results from the Dallas Heart Study [J].
de Lemos, JA ;
Zirlik, A ;
Schönbeck, U ;
Varo, N ;
Murphy, SA ;
Khera, A ;
McGuire, DK ;
Stanek, G ;
Lo, HS ;
Nuzzo, R ;
Morrow, DA ;
Peshock, R ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2192-2196
[9]   High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke [J].
Elkind, Mitchell S. V. ;
Tai, Wanling ;
Coates, Kristen ;
Paik, Myunghee C. ;
Sacco, Ralph L. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) :2073-2080
[10]  
Garza CA, 2007, MAYO CLIN PROC, V82, P159